Intellipharmaceutics International Inc. (IPCI)

[WeeZuhl]

Be careful here.

NDA resubmission this Quarter will make this stock one of the cheapest FDA play . Garbage or not i dont care because most Biotechs with very low valuation running up fast before FDA decision and thats why im in .

First, this company never meets their self-declared timelines. Even the original Rexista submission was months behind what they said. Second, there is one big unknown in the way, which is NASDAQ listing. If IPCI goes to the OTC, which is entirely possible, if not probable, then you're still looking at a significant haircut before this moves forward. If they maintain NASDAQ listing, you probably made a good bet. Beyond the NASDAQ determination, however, I agree that, at some point near here, with $14.3M in cash to advance multiple new projects, this starts to look like a good buy.


But whatever you do: assume the worst, assume everything they say is hopeful guessing at best, assume the PR's are intentionally misleading, as they have been in the past. And for God's sake, don't bet any money you can't afford to lose. This stock is a high-risk speculative bet. It always was.